Paul Stoffels

2.1k total citations
15 papers, 605 citations indexed

About

Paul Stoffels is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Paul Stoffels has authored 15 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Paul Stoffels's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (3 papers). Paul Stoffels is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (3 papers). Paul Stoffels collaborates with scholars based in Belgium, Germany and United States. Paul Stoffels's co-authors include Francis S. Collins, Rudi Pauwels, Koen Andries, Zeger Debyser, Anne–Mieke Vandamme, Aditya K. Gupta, Piet De Doncker, Annie Heremans, Robert Woestenborghs and C. Janssen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Paul Stoffels

15 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Stoffels Belgium 10 429 288 181 85 46 15 605
Sherry L. Orloff United States 14 610 1.4× 547 1.9× 279 1.5× 130 1.5× 29 0.6× 18 929
Ladislav Machala Czechia 16 460 1.1× 376 1.3× 259 1.4× 95 1.1× 27 0.6× 40 757
Nompumelelo P. Mkhwanazi South Africa 12 354 0.8× 210 0.7× 190 1.0× 55 0.6× 28 0.6× 26 536
Janin Nouhin Cambodia 15 876 2.0× 278 1.0× 172 1.0× 227 2.7× 11 0.2× 32 1.1k
Martin Delaney United States 5 444 1.0× 583 2.0× 153 0.8× 211 2.5× 8 0.2× 9 873
Jean‐Claude Schmit Luxembourg 23 1.0k 2.4× 1.0k 3.5× 250 1.4× 141 1.7× 46 1.0× 51 1.4k
Mariangela Raimondo Italy 12 265 0.6× 154 0.5× 206 1.1× 67 0.8× 5 0.1× 36 489
Debra P. Merrill United States 12 558 1.3× 573 2.0× 132 0.7× 89 1.0× 41 0.9× 16 742
Christian Tourrès France 15 556 1.3× 604 2.1× 160 0.9× 92 1.1× 12 0.3× 25 742
Jay A. Levy United States 7 203 0.5× 223 0.8× 164 0.9× 54 0.6× 5 0.1× 8 397

Countries citing papers authored by Paul Stoffels

Since Specialization
Citations

This map shows the geographic impact of Paul Stoffels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Stoffels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Stoffels more than expected).

Fields of papers citing papers by Paul Stoffels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Stoffels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Stoffels. The network helps show where Paul Stoffels may publish in the future.

Co-authorship network of co-authors of Paul Stoffels

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Stoffels. A scholar is included among the top collaborators of Paul Stoffels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Stoffels. Paul Stoffels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Collins, Francis S. & Paul Stoffels. (2020). Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV). JAMA. 323(24). 2455–2455. 80 indexed citations
2.
Røttingen, John-Arne, Dimitrios Gouglas, Mark B. Feinberg, et al.. (2017). New Vaccines against Epidemic Infectious Diseases. New England Journal of Medicine. 376(7). 610–613. 60 indexed citations
3.
Miller, Veronica, Marie‐Pierre de Béthune, Martin Stürmer, et al.. (1998). Patterns of Resistance and Cross-Resistance to Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors in Patients Treated with the Nonnucleoside Reverse Transcriptase Inhibitor Loviride. Antimicrobial Agents and Chemotherapy. 42(12). 3123–3129. 53 indexed citations
4.
Gupta, Aditya K., Piet De Doncker, Annie Heremans, et al.. (1997). Itraconazole for the treatment of tinea pedis: A dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks. Journal of the American Academy of Dermatology. 36(5). 789–792. 23 indexed citations
5.
Doncker, Piet De, Aditya K. Gupta, G. Marynissen, Paul Stoffels, & Annie Heremans. (1997). Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overview. Journal of the American Academy of Dermatology. 37(6). 969–974. 73 indexed citations
6.
Staszewski, Schlomo, Veronica Miller, Robert Colebunders, et al.. (1996). Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Antiviral Therapy. 1(1). 43–51. 5 indexed citations
7.
Miller, Veronica, Thomas Stark, J. De Crée, et al.. (1996). Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients. AIDS. 10(5). F1–F7. 72 indexed citations
8.
Staszewski, Schlomo, Miller, Robert Colebunders, et al.. (1996). Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study Group.. PubMed. 1(1). 42–50. 10 indexed citations
9.
Pauwels, Rudi, Marie‐Pierre de Béthune, Koen Andries, et al.. (1995). Discovery, Development and Characterization of Agents Active Against the Aids Virus. Journal of Receptors and Signal Transduction. 15(1-4). 609–616. 1 indexed citations
10.
Verhaegen, H., et al.. (1995). A simple and rapid flow cytometric method to measure lymphocyte activation in HIV+ subjects. Diminished response to pokeweed mitogen in early disease.. PubMed. 8(4). 345–55. 2 indexed citations
11.
Vandamme, Anne–Mieke, Zeger Debyser, Rudi Pauwels, et al.. (1994). Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913. AIDS Research and Human Retroviruses. 10(1). 39–46. 36 indexed citations
12.
Pauwels, Rudi, Koen Andries, Zeger Debyser, et al.. (1993). Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.. Proceedings of the National Academy of Sciences. 90(5). 1711–1715. 164 indexed citations
13.
Stoffels, Paul, et al.. (1991). Focus on itraconazole. Indian Journal of Dermatology Venereology and Leprology. 57(1). 4–16. 3 indexed citations
14.
Pialoux, Gilles, B. Dupont, M Youle, et al.. (1991). Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex. The Lancet. 338(8760). 140–143. 22 indexed citations
15.
Kayembé, Patrick, et al.. (1989). Diclazuril for Isospora belli infection in AIDS [letter]. 1397–1398. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026